Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

300558.SZ Gross Margin

The Gross Margin of Betta Pharmaceuticals Co Ltd (300558.SZ) is 81.38%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

300558.SZ Gross Margin - Historical Value
Date Value
2024-12-31 81.38%
2023-12-31 83.53%
2022-12-31 88.69%
2021-12-31 92.23%
2020-12-31 92.57%
2019-12-31 93.23%
2018-12-31 94.36%
2017-12-31 95.74%
2016-12-31 96.83%
2015-12-31 96.94%
300558.SZ Gross Margin - Peers Comparison
Ticker Name Value
000739.SZ Apeloa Pharmaceutical Co Ltd 23.26%
600566.SS Hubei Jumpcan Pharmaceutical Co Ltd 79.21%
002603.SZ Shijiazhuang Yiling Pharmaceutical Co Ltd 46.47%
300357.SZ Zhejiang Wolwo Bio-Pharmaceutical Co Ltd 95.16%
300702.SZ Zhejiang Tianyu Pharmaceutical Co Ltd 33.06%
000513.SZ Livzon Pharmaceutical Group Inc 64.80%
000623.SZ Jilin Aodong Pharmaceutical Group Co Ltd 38.62%
300363.SZ Porton Pharma Solutions Ltd 23.33%
600867.SS Tonghua Dongbao Pharmaceutical Co Ltd 72.75%
688526.SS Wuhan Keqian Biology Co Ltd 62.40%
002399.SZ Shenzhen Hepalink Pharmaceutical Group Co Ltd 33.10%
2096.HK Simcere Pharmaceutical Group Ltd 80.25%
002821.SZ Asymchem Laboratories (Tianjin) Co Ltd 41.55%
603456.SS Zhejiang Jiuzhou Pharmaceutical Co Ltd 30.89%
867.HK China Medical System Holdings Ltd 72.60%
002019.SZ Yifan Pharmaceutical Co Ltd 46.79%
002099.SZ Zhejiang Hisoar Pharmaceutical Co Ltd 18.31%
600521.SS Zhejiang Huahai Pharmaceutical Co Ltd 60.85%
603520.SS Zhejiang Starry Pharmaceutical Co Ltd 18.31%
000423.SZ Dong-E-E-Jiao Co Ltd 72.57%
002626.SZ Xiamen Kingdomway Group Co 38.33%
300630.SZ Hainan Poly Pharm Co Ltd 72.65%
603707.SS Nanjing King-friend Biochemical Pharmaceutical Co Ltd 46.17%
002294.SZ Shenzhen Salubris Pharmaceuticals Co Ltd 71.63%
002653.SZ Haisco Pharmaceutical Group Co Ltd 71.47%
688321.SS Shenzhen Chipscreen Biosciences Co Ltd 86.71%
002773.SZ Chengdu Kanghong Pharmaceutical Group Co Ltd 89.46%
460.HK Sihuan Pharmaceutical Holdings Group Ltd 65.32%